文献速递儿童内分泌与遗传代谢

儿童2型糖尿病真实世界血糖控制:一项基于人群的研究

Real-Life Glycemic Control in Children with Type 2 Diabetes: A Population-Based Study.
PubMed 文献 · J Pediatr · 2017-07-08

该研究基于以色列大型健康维护组织数据库,纳入9年间诊断的96例儿童青少年2型糖尿病患者,分析其 demographic、人体测量、临床及实验室数据。随访结束时超过50%患者使用胰岛素治疗,中位HbA1c为7.97%,44.6%患者达到HbA1c<7.0%的目标。多变量线性回归显示,诊断时较高的HbA1c、较高的BMI SD评分、较少的年度HbA1c检测次数及阿拉伯裔是以较差血糖控制的预测因素。

要点

  • 随访结束时超过50%的儿童2型糖尿病患者需胰岛素治疗,中位HbA1c为7.97%。
  • 44.6%的患者达到HbA1c<7.0%的目标,说明社区和门诊环境下可实现合理血糖控制。
  • 诊断时HbA1c较高、BMI SD评分较高、年度HbA1c检测次数较少及阿拉伯裔与更差血糖控制相关。

核心结论

  • 该基于人群的研究表明,在社区和门诊医院环境中,儿童2型糖尿病患者可实现合理的血糖控制,但仍有改进空间以优化结局并降低并发症风险。

主要发现

  • 诊断时平均年龄为14.25±2.51岁,中位HbA1c为7.8%,代谢综合征其他组分存在于14.9%-67.4%的患者中。
  • 随访结束时(3.11±1.75年),超过50%患者接受胰岛素治疗,中位HbA1c为7.97%,44.6%患者达到HbA1c<7.0%的目标。
  • 多变量线性回归分析显示,预测更差血糖控制(即更高HbA1c)的变量包括诊断时较高的HbA1c、诊断时较高的BMI SD评分、较少的年度HbA1c检测次数及阿拉伯裔(F(4,81)=7.139;P<.001;R2=0.271)。

关键数值与推荐

  • 血糖控制目标为HbA1c<7.0%,研究中44.6%的患者达到该目标。
  • 多变量线性回归模型纳入诊断时HbA1c、诊断时BMI SD评分、年度HbA1c检测次数及阿拉伯裔,模型F(4,81)=7.139,P<.001,R2=0.271。

临床怎么用

  • 对于儿童2型糖尿病患者,应关注诊断时HbA1c较高、BMI SD评分较高及阿拉伯裔等与更差血糖控制相关的因素,并加强年度HbA1c检测。
  • 在社区和门诊环境中可实现合理血糖控制,但需针对可改善因素(如检测频率、体重管理)优化干预以降低并发症风险。

局限性

  • 研究为基于单一健康维护组织数据库的回顾性分析,样本量较小(96例),可能限制结果的普遍性。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterize children and adolescents with type 2 diabetes mellitus (T2DM) insured by a large health maintenance organization, and to identify variables associated with treatment quality and disease outcome. STUDY DESIGN: Children and adolescents diagnosed with T2DM over a 9-year period were identified from the database of Clalit Health Services, a large health maintenance organization in Israel (1 213 362 members aged 0-18 years). Demographic, anthropometric, clinical, and laboratory data were analyzed. RESULTS: A total of 96 patients (47 males) met our inclusion criteria. The mean age at diagnosis of T2DM was 14.25 ± 2.51 years. At the time of diagnosis, the median hemoglobin A1c (HbA1c) level was 7.8%, and additional components of the metabolic syndrome were present in 14.9%-67.4% of the patients. At the end of the follow-up period (3.11 ± 1.75 years), >50% of the patients were being treated with insulin; the median HbA1c value was 7.97%, and 44.6% of the patients achieved the target HbA1c of <7.0%. On multivariate linear regression analysis, the variables found to predict worse glycemic control (ie, higher HbA1c) were a higher HbA1c at diagnosis, a higher body mass index SD score at diagnosis, fewer annual HbA1c tests, and Arabic ethnicity [F(4,81) = 7.139; P < .001; R2 = 0.271]. CONCLUSION: This population-based study of pediatric patients with T2DM demonstrates that reasonable glycemic control can be achieved in both community and outpatient hospital settings. Nevertheless, there is room for improvement in intervention programs to optimize outcomes and decrease the risk of complications.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Meyerovitch J, Zlotnik M, Yackobovitch-Gavan M, et al. Real-Life Glycemic Control in Children with Type 2 Diabetes: A Population-Based Study. J Pediatr. 2017. PMID: 28693789. doi:10.1016/j.jpeds.2017.05.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。